Substance Use Disorder Short Acting Medication

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259" ]
    } ]
  },
  "date" : "2024-01-24T01:11:59-05:00",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2024-01-24T09:53:01.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)",
  "name" : "SubstanceUseDisorderShortActingMedication",
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1010600",
      "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1010604",
      "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Film",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1307056",
      "display" : "buprenorphine 4 MG / naloxone 1 MG Sublingual Film",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1307061",
      "display" : "buprenorphine 12 MG / naloxone 3 MG Sublingual Film",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1431076",
      "display" : "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1431102",
      "display" : "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1483744",
      "display" : "naltrexone hydrochloride 50 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1542390",
      "display" : "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1544851",
      "display" : "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1544854",
      "display" : "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1597568",
      "display" : "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1597573",
      "display" : "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1666338",
      "display" : "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1864412",
      "display" : "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197623",
      "display" : "disulfiram 250 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197624",
      "display" : "disulfiram 500 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351264",
      "display" : "buprenorphine 2 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351265",
      "display" : "buprenorphine 8 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351266",
      "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351267",
      "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "835726",
      "display" : "acamprosate calcium 333 MG Delayed Release Oral Tablet",
      "version" : "05062024"
    } ],
    "total" : 21,
    "identifier" : "urn:uuid:2d25e574-9899-47d1-9d42-bd289d0b5f1f",
    "timestamp" : "2024-06-14T17:00:14-04:00"
  },
  "title" : "Substance Use Disorder Short Acting Medication",
  "extension" : [ {
    "valueString" : "NCQA PHEMUR Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-01-24",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2024-01-24",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "2.16.840.1.113883.3.464.1003.1150",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.464.1003.1150"
  } ],
  "version" : "20240124"
}